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Abstract The two human proteins Ki-1/57 and CGI-55 have
highly similar amino acid sequences but their functions are un-
known. We analyzed them by yeast two-hybrid screens and
found that they interact with the C-terminal region of the hu-
man chromatin-remodeling factor CHD-3 (chromo-helicase-
DNA-binding domain protein-3). The interaction of CGI-55
and CHD-3 could be con¢rmed in vitro and in vivo by co-im-
munoprecipitations from Sf9 insect cells. Mapping showed that
CGI-55 interacts with CHD-3 via two regions at its N- and C-
terminals. The CGI-55 and Ki-1/57 mRNAs show highest ex-
pression in muscle, colon and kidney. A CGI55^GFP fusion
protein was localized in the cytoplasm, nucleus and perinuclear
regions of HeLa cells. These data suggest the possibility that
CGI-55 and Ki-1/57 might be involved in nuclear functions like
the remodeling of chromatin.
6 2002 Published by Elsevier Science B.V. on behalf of the
Federation of European Biochemical Societies.
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1. Introduction
Using the monoclonal antibody Ki-1, the ¢rst antibody
described that speci¢cally detects the malignant Hodgkin
and Sternberg-Reed cells in Hodgkin lymphoma [1], we
have previously identi¢ed the antigen Ki-1/57, a 57 kDa intra-
cellular phospho-protein [2,3]. In vitro phosphorylation ex-
periments performed with the Ki-1/57 antigen isolated from
tumor cells suggested that it is associated with a serine/threo-
nine protein kinase activity [4]. Electron microscopic analysis
demonstrated that the Ki-1/57 antigen is not only located in
the cytoplasm but also at the nuclear pores and in the nucleus
where it is frequently found in association with the nucleolus
[5]. Tryptic digestion of the Ki-1/57 antigen resulted in the
cloning of a partial cDNA encoding Ki-1/57 [6]. The isolated
contig of 1380 bp length, encoded the C-terminal 60% of the
Ki-1/57 protein.
By searching for related proteins we discovered a cDNA
sequence encoding the protein CGI-55, a possible human pa-
ralog of the Ki-1/57 protein of yet unknown function. Its
cDNA is complete and encodes a hypothetical protein of 55
kDa. The protein sequence of CGI-55 shows 40.7% identity
and 67.4% similarity with Ki-1/57. This suggests that the two
human proteins might be paralogs and have similar functions.
In the present study, we wanted to obtain possible clues
about the functional context of the proteins CGI-55 and Ki-
1/57. We explored the yeast two-hybrid system to identify
possible interacting proteins. We found that CGI-55 and Ki-
1/57 interact with the C-terminal region of the human protein
CHD-3 (chromo-helicase DNA-binding domain protein-3).
The CHD proteins are members of the chromodomain family,
a class of proteins that are involved in transcriptional regu-
lation and chromatin remodeling [7^16]. Chromatin remodel-
ing is likely to be an important step for the regulation of gene
expression next to transcription factor based regulatory mech-
anisms [17,18]. Proteins that participate in the remodeling of
chromatin might a¡ect this process at levels as diverse as the
nucleosome packing, the formation of DNA loops, its super-
coiling or its attachment to the nuclear matrix [18]. The bind-
ing of the proteins CGI-55 and Ki-1/57 to CHD-3 can de¢ne
them as new family of CHD-3 binding proteins and suggests
the possibility that they might be involved in nuclear functions
associated with the remodeling of chromatin.
2. Materials and methods
2.1. Plasmid construction
The full-length cDNA (DKFZp564M2423Q3) described in the da-
tabase report was kindly provided by the Resource Center/Primary
Database (Heubnerweg 6, D-14059 Berlin, Germany). This clone had
been isolated from a human fetal brain cDNA library (DKFZhfb2)
created by Stefan Wiemann (DKFZ, Heidelberg, Germany). Several
sets of oligonucleotides were designed to allow sub-cloning of the
complete CGI-55 coding region in di¡erent expression vectors. Inser-
tion into pGEX-2TK (Amersham Biosciences) allowed to express
CGI-55 (1^387) as a C-terminal fusion to GST (GST^CGI55). The
cDNAs of CGI-55 and its deletion constructs were also inserted into
the yeast two-hybrid expression vector pBTM-116 [19]. In a similar
fashion the cDNA fragment encoding the C-terminal 60% of the Ki-1/
57 antigen (122^413) was inserted in pBTM116. The cDNAs encoding
CGI-55 (1^387), Ki-1/57 (1^413) and the C-terminal of CHD-3 (1839^
2000) were inserted into the baculovirus (BV) transfervector pVL1392
vector (Pharmingen). This CHD-3 fusion protein contains N-terminal
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HA- and 6UHis tags for immunodetection (6UHis-HA-CHD3). The
complete cDNA of CGI-55 was cloned into vector pEGFP-N1 (Clon-
tech).
2.2. Northern blot analysis
A human 12-lane multiple tissue Northern RNA blot was obtained
from Clontech and consisted of poly(A)-enriched RNA from the fol-
lowing tissues: brain, heart, skeletal muscle, colon, thymus, spleen,
kidney, liver, small intestine, placenta, lung, and peripheral blood
leukocytes. A cDNA fragment of 1161 bp length encompassing the
whole coding region of the CGI-55 protein was radiolabeled with K-
[32P]dATP using the random prime labeling kit (Roche). Hybridiza-
tion and exposure of membranes to Kodak ¢lms were performed ac-
cording to manufacturer of membrane (Clontech). The membrane was
subsequently striped and reprobed ¢rst with a Ki-1/57 cDNA probe of
550 bp length and ¢nally with the 2 kb control actin probe.
2.3. Yeast two-hybrid screening and interaction analysis
The pBTM116-CGI-55 [19] and pBTM116-Ki-1/57 (122^413) vec-
tors were used to express the proteins CGI-55 and Ki-1/57 (C-termi-
nal) linked to the C-terminus of LexA DNA-binding domain peptide
in Saccharomyces cerevisiae strain L40. A human fetal brain cDNA
library (Clontech) expressing GAL4 activation domain (AD) fusion
proteins was co-transformed separately with both recombinant
pBTM116 vectors. Selection of transformants, L-galactosidase activity
test, plasmid DNA extraction and sequencing were performed as de-
scribed [20].
2.4. Bacterial expression and protein puri¢cation
GST and GST^CGI55 proteins were expressed in Escherichia coli
BL21-CodonPlus-RIL (Stratagene), and puri¢ed using glutathione^
Sepharose 4B (Amersham) according to manufacturer.
2.5. Expression of 6UHis-HA-CHD3, 6UHis-CGI55 and Ki-1/57 in
Sf9 insect cells
The recombinant transfer vectors pVL1393-HA-CHD3, pVL1392-
CGI55 or pVL1392-Ki-1/57 were co-transfected with BV DNA (Ba-
culoGold1, Pharmingen) in Sf9 insect cells by lipid transfection (DO-
TAP, Roche). Recombinant BV were separately ampli¢ed three to
four times with fresh Sf9 cells. Cells were collected and sonicated in
PBS, 0,1% Triton X-100 with protease inhibitors. 6UHis-HA-CHD3
was puri¢ed by Ni-NTA Sepharose a⁄nity chromatography.
2.6. Production of anti-CGI-55 monoclonal antibody
Monoclonal antibodies against CGI-55 were essentially generated
as described [6,21]. Brie£y, BALB/c mice were immunized four times
with intervals of 2^4 weeks intraperitoneally with 100 Wg of bacterial
GST^CGI55 fusion protein. Spleen cells were fused with X63-Ag8.653
myeloma cells. Hybridoma supernatants were screened by ELISA for
the presence of CGI-55 antibodies. The supernatant of re-cloned anti-
CGI-55 hybridoma 10.5.6 was used for the experiments.
2.7. In vitro binding assay and Western blot analysis
14 Wg of 6UHis-HA-CHD3 (1839^2000) fusion protein was coupled
to Ni-NTA Sepharose beads. Next 14 Wg of GST^CGI55 or GST
control protein were incubated for 2 h with the beads and then
washed with bu¡er (20 mM Tris^HCl, pH 7.5, 150 mM NaCl). Pro-
teins bound to the beads were separated by SDS^PAGE, transferred
to a PDVF membrane and visualized by immuno-chemiluminescence
using a mouse anti-GST antibody and secondary anti-mouse IgG-
HRP conjugate.
2.8. In vivo binding assay and Western blot analysis
1.0U107 Sf9 cells were infected with wild type BV (BV-WT) or
recombinant BV (BV-6UHis-HA-CHD3(1839^2000), BV-6UHis-
CGI55, BV-Ki-1/57) at a multiplicity of infection s 20. Two days
after infection, cells were lysed in 1 ml Tris^HCl (pH 8.5) containing
protease inhibitors. Lysate was treated with DNase (Promega) and
cleared at 14 000Ug for 15 min. Next 20 Wl protein A Sepharose beads
(Pharmacia) were loaded with the indicated antibodies (anti-HA
mAb: Clontech), washed (Tris^HCl, pH 8.5) and incubated with the
indicated lysates for 2 h at 4‡C. After further two washes with the
same bu¡er the beads were resuspended in SDS^PAGE loading bu¡-
er, boiled and analyzed by SDS^PAGE and Western blot using di¡er-
ent mAb.
Western blots were developed by chemiluminescence as described
[20].
2.9. Analysis of CGI55^EGFP (enhanced green £uorescence protein)
fusion protein by £uorescence microscopy
HeLa cells were maintained at 37‡C in 5% CO2 in Dulbecco’s
modi¢ed Eagle’s medium containing 10% heat inactivated fetal calf
serum. Cells were cultured on glass coverslips for 24 h and were
transfected with either wild type pEGFP vector (Clontech) or with
recombinant vector CGI55^pEGFP-N1 using the lipid transfection
method (Lipofectamine, Invitrogen). After 24 h coverslips were
washed and mounted in 80% glycerol/10 mM Tris^HCl (pH 7.5) on
coverglasses and analyzed with a £uorescence microscope (Eclipse
E600, Nikon).
3. Results
3.1. Sequence analysis of CGI-55 and Ki-1/57
An alignment of the deduced amino acid sequences of hu-
man CGI-55, human Ki-1/57 and a possible Caenorhabditis
elegans CGI-55 ortholog (Fig. 1) revealed possible ATP-bind-
ing motifs and nuclear localization signals. The central of the
two ATP-binding motifs present in the CGI-55 sequence is
conserved in the Ki-1/57 sequence and also in an ortholog
protein sequence from C. elegans, whereas the possible C-ter-
minal ATP-binding motif of CGI-55 is not conserved in the
other two proteins. The putative nuclear localization sequence
Fig. 1. Protein sequence alignment of human Ki-1/57, human CGI-
55 and C. elegans CGI-55. A: Comparison of huKi-1/57 (U77327
and AF241831), huCGI-55 (AL080119 and AF151813) and CeCGI-
55 (CGI-55 from C. elegans : AF016672). Asterisks (*) indicate iden-
tical whereas colons (:) mark similar residues. Predicted ATP-bind-
ing motifs are boxed. Basic motif: G-X-G-X-X-G-(X)1322-K;
[26,27] with white highlighting. Putative NLSs were predicted by the
program PSORT II and are indicated by boxes and gray highlight-
ing. B: Table comparing the identity (*) and similarity (:) values be-
tween the analyzed protein sequences.
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(NLS) of CGI-55 begins at proline 132, whereas that of Ki-1/
57 is located closer to the N-terminus at arginine 55. The
amino acid sequence similarity between Ki-1/57 and CGI-55
is high: 40.7% of the residues are identical and 16.7% are
similar. These data suggest that both human proteins might
be paralogs with similar or overlapping functions. In the C.
elegans amino acid sequence only the N-terminal of the ATP-
binding motifs is conserved. Its NLS is found approximately
20 amino acids downstream of that found in the human CGI-
55 (proline 153).
3.2. Comparison of the tissue expression of CGI-55 and Ki-1/57
To investigate the human CGI-55 and Ki-1/57 expression
pattern in di¡erent human tissues we conducted a Northern
blot analysis. As shown in Fig. 2 two major transcripts of
human CGI-55, of V5.5 kb and V4 kb as well as a minor
transcript of V2.2 kb, were observed. The ¢rst two tran-
scripts might be unprocessed pre-mRNA, whereas the tran-
script ofV2.2 kb is the mature CGI-55 transcript. The signal
intensity decreases in the order: heart, skeletal muscle, kidney,
placenta, liver and brain. The other tissues showed only very
faint bands of the two larger CGI-55 transcripts, indicating
low levels of CGI-55 expression in these tissues. In contrast,
two transcripts of human Ki-1/57 of V2.8 kb and V2 kb
were observed in the order of decreasing signal intensity in
brain, kidney, heart, and skeletal muscle. All other tissues
showed weak expression of predominantly the V2 kb tran-
script. A control hybridization with the L-actin probe con-
¢rmed the uniform loading of the lanes with poly(A)þ RNA.
3.3. Yeast two-hybrid screens
To gain functional insights via the identi¢cation of interact-
ing proteins of CGI-55 and Ki-1/57, the yeast two-hybrid
system [19,20,22,23] was employed, utilizing a human fetal
brain cDNA library. For CGI-55 a screen of 0.6U106 co-
transformants yielded 125 clones positive for both His3 and
Fig. 2. Di¡erential expression of CGI-55 and Ki-1/57 mRNAs in human tissues. A Northern blot of poly(A)þ RNA isolated from several hu-
man tissues (Clonetech) was hybridized with human CGI-55 (A), Ki-1/57 (B) and L-actin (C) cDNA probes.
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LacZ reporter constructs. Library plasmids of 19 clones were
sequenced. 42% of the sequenced clones encoded the C-termi-
nal region of human chromatin remodeling factor CHD-3
(amino acid residues 1551^2000) (Fig. 3) [13]. All clones rep-
resent an alternative version of the CHD-3 protein that prob-
ably rises through alternative splicing and had been termed
SNF2-like zinc-¢nger helicase [11,13] (Fig. 3B). For Ki-1/57
we performed a two-hybrid screen of the same cDNA library
using the construct pBTM116-Ki-1/57(122^413). We isolated
three independent alternatively spliced CHD-3 clones (Fig. 3).
3.4. Mapping the interaction site of CGI-55 with CHD-3
Next, we mapped the CGI-55 region required for the inter-
action CHD-3 using the yeast 2-hybrid method (Fig. 4). N-
and C-terminal deletion constructs of the CGI-55 protein were
fused to the lexA DNA-binding domain and tested for their
ability to bind CHD-3. Only the construct 4 of CGI-55 (128^
259), that contains the central region of CGI-55, failed to bind
to CHD-3. The co-transformation of pBTM116-CHD3(1893^
2000) with an unrelated ‘bait’ construction (pBTM116-AUF1)
[24] showed no interaction. Our data suggest that CGI-55
interacts with CHD-3 via two independent binding sites that
are located in its N- and C-terminal regions.
3.5. In vitro con¢rmation of the CGI55^CHD-3 interaction
with puri¢ed proteins
We carried out pull down assay with puri¢ed recombinant
proteins that had been expressed in E. coli (GST, GST^
CGI55) or in the BV system (6UHis-HA-CHD3) to con¢rm
the interaction between CGI-55 and CHD-3 in vitro. As
shown in Fig. 5B GST^CGI55 bound speci¢cally to the C-
terminal of CHD-3, while the control protein GST did not.
The input controls identify the corresponding proteins in the
blot. In Fig. 5A we controlled the equal loading of the Ni-
NTA Sepharose beads with 6UHis-HA-CHD3(1893^2000) by
developing the Western blot with an anti-4UHis mAb.
3.6. Co-immunoprecipitation from BV infected Sf9 insect cells
In order to test if CGI-55 (or Ki-1/57) and CHD-3 can form
a stable complex when they are co-expressed in animal cells
we employed the BV expression system for co-infection and
co-immunoprecipitation studies. When Sf9 cells were co-in-
fected with the two recombinant BVs BV-HA-CHD3(1893^
2000) and BV-CGI55 and the recombinant protein HA-
CHD3(1893^2000) was immunoprecipitated with an anti-HA
tag mAb, the protein CGI-55 co-precipitated (Fig. 5C, lane 3)
and could be detected by an immunoblot with anti-CGI55
mAb. This immunoprecipitation was speci¢c, since no CGI-
55 protein was detected when the Sf9 cells were infected with
BV-WT or with the recombinant BV-HA-CHD3 alone (Fig.
5C, lanes 1 and 2). The lysate of the Sf9 cells infected with
BV-CGI55 alone was used to identify the recombinant CGI55
protein in the anti-CGI55 immunoblot (Input lane; Fig. 5C,
lane 4). In a similar fashion when CGI-55 was immunopreci-
pitated (using ant-CGI55 mAb 10.5.6) the protein HA-
CHD3(1893^2000) co-precipitated only from the lysate of
Sf9 cells that had been co-infected by both recombinant
BVs: BV-HA-CHD3 and BV-CGI55 (Fig. 5D, lane 3). The
immunoprecipitation of lysates of Sf9 cells that had been in-
fected with BV-WT or BV-CGI55 alone, did not result in the
Fig. 3. CGI-55 and Ki-1/57 interact with the C-terminal region of CHD-3. A: Schematic representation of the domain organization of the hu-
man protein CHD-3. The position and of the identi¢ed CGI-55 interacting clones is shown along the full-length CHD-3 protein. The ruler indi-
cates the length of CHD-3 in amino acids. B: Sequence alignment of the classical [13] and alternatively spliced C-terminal of CHD-3 [11].
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detection of HA-CHD3 protein (Fig. 5D, lanes 1 and 2). The
lysate of Sf9 cells infected only with BV-HA-CHD3 identi¢es
the HA-CHD3 protein in the anti-HA immunoblot (Fig. 5D,
lane 4, Input). In a parallel approach we were able to dem-
onstrate that also Ki-1/57 speci¢cally co-precipitates with HA-
CHD3 protein (Fig. 5E).
3.7. Subcellular localization of CGI-55
Human HeLa cells were transfected with a vector contain-
ing GFP alone or with a vector that contains the cDNA
encoding CGI-55 fused to the N-terminal of GFP (Fig. 6).
In the control an even distribution of GFP was observed in
the HeLa cells. In the case of the CGI55^GFP fusion con-
struct we observed a less intense overall staining that appeared
in a punctuated pattern throughout the cell. The speckled
pattern was found in both the cytoplasm and to a lesser ex-
tend also in the nucleus. In addition we observed a marked
perinuclear accumulation of the £uorescence in the transfected
cells.
4. Discussion
Very few functional data exist about the proteins CGI-55
and Ki-1/57 [6,25,28]. The data that are available in the liter-
ature so far suggest, that CGI-55 (also named PAI-RBP1 for
plasminogen activator inhibitor mRNA^RNA-binding pro-
tein 1) is a mRNA-binding protein [28]. These researchers
studied proteins that bind to the 3P-terminal most 134 nt of
the PAI-1 (plasminogen activator inhibitor 1) mRNA, that
might be involved in the control of this mRNA’s stability.
They suggested that CGI-55 might be a protein that is in-
volved in the regulation of the stability of the PAI-1 mRNA.
The only functional studies concerning Ki-1/57 come from
our group [2^6] and from one other group [25]. The latter had
described Ki-1/57 as a novel hyaluronan-binding protein and
re-named it IHABP4 (for intracellular hyaluronan binding
protein 4). They also found that IHABP4 (=Ki-1/57) binds
to other negatively charged glycosaminoglycans like chondroi-
tin sulfate, heparane sulfate, and also RNA, although with
lower a⁄nity. The binding of IHABP4/Ki-1/57 to a series of
negatively charged macromolecules might be due to its rela-
tively high content of positively charged amino acids, in par-
ticular Arg (12.8%). The biological meaning of the interaction
of a protein localized in the cytoplasma and nucleus [2^5,25]
with glycosaminoglycans, which are mainly found outside the
cell [25], remains open.
Fig. 4. Mapping of the regions of CGI-55 that interact with CHD-3. A: Various N- and C-terminal truncations of human CGI-55 were fused
in frame to the DNA-binding domain of lexA in plasmid pACT2 and transformed into yeast L40 together with the fusion CHD3-Gal4-AD
cloned in pBTM116. B: Interaction was determined by the ability of the co-transformant cells to grow on minimal medium (MM),-W,-L,-H
(right). Presence of ‘bait’ and ‘prey’ plasmids in the co-transformed cells was controlled by growth on MM-W,-L (left).
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In order to identify a functional context for the protein
paralogs Ki-1/57 and CGI-55 we set out to perform yeast
two-hybrid screens to identify possible interacting protein
partners. Screens of a human fetal brain cDNA library with
both CGI-55 and Ki-/57 identi¢ed an alternative spliced ver-
sion of the DNA remodeling factor CHD-3. The longest
CHD-3 clone encodes its C-terminal 412 amino acids and
includes part of the predicted DNA-binding domain. The
shortest of the interacting clones however, includes only the
C-terminal 161 amino acids of the CHD-3 protein, suggesting
that the interaction occurs in a very de¢ned region at the C-
terminal region of CHD-3. Ki-1/57 also interacted with clones
that represent the C-terminal region (1807^2000) of CHD-3.
Our analysis of the sub-cellular localization of the EGFP^
CGI55 fusion protein in human HeLa cells suggests that CGI-
55 might have both cytoplasmic and nuclear functions and it
is tempting to speculate that the distribution of CGI-55 be-
tween these two compartments might be regulated like that of
other proteins shuttling between the nucleus and the cytoplas-
ma.
Fig. 5. In vitro binding assay and co-immunoprecipitation from Sf9 insect cells infected with di¡erent combinations of recombinant BV. A,B:
In vitro binding assay. Ni-NTA Sepharose beads were loaded with puri¢ed 6UHis-HA-CHD3(1983^2000) protein. Beads were then incubated
with puri¢ed GST or GST^CGI55, washed three times, separated by SDS^PAGE, transferred to PVDF membrane and probed with anti GST
antibody (B, lanes 1 and 2) or anti-4UHis mAb (A, lanes 1 and 2). Puri¢ed GST and GST^CGI55 proteins were used as input controls (B,
lanes 3 and 4). C,E: Co-immunoprecipitation of CGI-55 and Ki-1/57 with HA-CHD3. Sf9 cells were infected with the BV indicated on top of
the panel. C: HA-CHD3(1983^2000) was immunoprecipitated (IP) with anti-HA antibody. The immunoprecipitates were probed (IB, immuno-
blot) with anti-CGI-55 antibody 10.5.6. Input: expression and identity of CGI-55 were controlled by applying lysate of Sf9 cells infected with
BV-CGI55 (C, lane 4). D: CGI-55 was immunoprecipitated with antibody 10.5.6. Immunoprecipitates were probed with anti-HA antibody. In-
put: Lysate of Sf9 cells infected with BV-HA-CHD3 (D, lane 4). E: HA-CHD3(1983^2000) was immunoprecipitated with anti-HA antibody.
The immunoprecipitates were probed with anti-Ki-1/57 antibody Ki-1. Input: Lysate of Sf9 cells infected with BV-Ki-1/57. Molecular mass
markers are shown in kDa on left side of the panels. Arrows on the right indicate speci¢c proteins identi¢ed by immunoblot.
Fig. 6. Cellular Localization of CGI55^EGFP. HeLa cells were transiently transfected with expression vector pEGFP or recombinant expression
vector CGI55^pEGFP-N1. After 24 h transfected cells were examined with a Nikon microscope.
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In summary, the new functional data on the homologous
proteins Ki-1/57 and CGI-55 that we described here, demon-
strate that these proteins interact with the nuclear protein
CHD-3, which is involved in chromatin-remodeling and tran-
scriptional regulation. To our knowledge, this is the ¢rst re-
port that describes a speci¢c protein^protein interaction for
CGI-55 and Ki-1/57 and might de¢ne them as a new family of
proteins. It is tempting to speculate that these interactions
might be relevant for the regulation of the CHD-3 mediated
chromatin-remodeling.
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